Reference(s) to `NCCc1ccc(O)c(O)c1' in wdi981demo:
Indications and usage
Myocardial-infarction; trauma; endotoxic sepsis; open-heart-surgery;low
cardiac-output; cardiac-failure; chronic cardiac-decompensation;impending
Precautions and warnings
Pregnancy; children; peripheral vascular-disease; avoid extravasation;
cyclopropane; halogenated hydrocarbon anesthetics; begin treatment with
one-tenth of the usual dose in those who have been treated with MAO-inhibitors;
correct hypovolemia if necessary prior to treatment; inject into a large
vein if possible; safety and efficacy in children have not been established;
use glucose solutions with care in diabetics; monitor with history of peripheral
vascular-disease for signs of compromized circulation to the extremities;
glucose solutions without electrolytes should not be administered simultaneously
with blood through the same infusion set; decrease infusion-rate in event
of a disproportionate increase in diastolic pressure and observe for further
evidence of predominant vasoconstriction unless this is desired.
Pheochromocytoma; uncorrected tachyarrhythmia; uncorrected ventricularfibrillation.
Cyclopropane; MAO-inhibitors; potassium-free solutions; halogenatedhydrocarbon
Ectopic-beats; tachycardia; arrhythmia; cardiopathy; angina-pectoris;palpitations;
dyspnea; nausea; coronary-disease; GI-disorder; vomiting;hypotension; vasoconstriction;
cardiac-conduction-disorder; hypertension;vascular-disease; bradycardia;
piloerection; widened QRS-complex; azotemia.
Mechanism of action
DOPAMINERGIC; PROLACTIN-ANTAGONIST; SYMPATHOMIMETIC-ALPHA;SYMPATHOMIMETIC-BETA;
VASODILATOR; HYPERTENSIVE; noradrenaline precursor;releases noradrenaline
stores natriuretic; acts directly and indirectly onalpha adrenergic-receptors
and beta-1 adrenergic-receptors; increases systolicB.P.; increases pulse-pressure
peripheral blood-flow may decrease; mesentericblood-flow may increase;
produces renal vasodilatation; produces mesentericvasodilatation; increases
glomerular filtration rate; inotropic effect on themyocardium resulting
in increased cardiac-output; increased urinary output isnot associated
with decreased urinary osmolality.
DOPAMIN, DOPAMINE, DOPAMINE-200, DOPAMINE-50
Daylight Chemical Information Systems Inc.